Synthetic Biology Focused Insights Report 2024: A $59.91 Billion Market by 2029, Driven by Rising Use in Multiplexed Diagnostics and Therapeutic Genome Editing
October 16, 2024 10:41 ET
|
Research and Markets
Dublin, Oct. 16, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Biology Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The Synthetic Biology Market was...
Cell Separation Technology Industry Analysis, 2024-2037: A $30+ Billion Opportunity with Research Labs and Institutes Generating the Most Revenue
October 14, 2024 10:12 ET
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Cell Separation Technology Market Outlook 2037" report has been added to ResearchAndMarkets.com's offering.The global market for cell...
QC Kinetix Celebrates PA Week Honoring Physician Assistants as 'The Miraculous Midlevel'
October 10, 2024 13:08 ET
|
QC Kinetix
Charlotte, North Carolina, Oct. 10, 2024 (GLOBE NEWSWIRE) -- From October 6-12, the American Academy of Physician Associates and QC Kinetix, a fast-growing regenerative medicine franchise that...
Protein Therapeutics Strategic Research Report 2023-2030: Rising Demand for Cost-Effective and Scalable Therapeutics Throws Spotlight on Market Adoption
October 08, 2024 04:37 ET
|
Research and Markets
Dublin, Oct. 08, 2024 (GLOBE NEWSWIRE) -- The "Protein Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Protein...
Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day
October 07, 2024 09:05 ET
|
Longeveron
Wa’el Hashad, Chief Executive Officer of Longeveron, will participate in a Fireside Chat at the UBS Virtual Organ Restoration and Cell Therapy Day Oct 15th
RTI Surgical Announces Agreement to Acquire Collagen Solutions
October 07, 2024 07:00 ET
|
RTI Surgical
RTI Surgical Announces Agreement to Acquire Collagen Solutions Further expands RTI’s soft tissue portfolio of xenograft and allograft materials at scaleImproves access to high-growth cardiac,...
Regenerative Medicine Market is Targeting USD 154.05 Billion by 2033
October 01, 2024 09:35 ET
|
Precedence Research
Ottawa, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The global regenerative medicine market size was valued at USD 29.42 billion in 2023 and is predicted to surpass around USD 154.05 billion by 2033,...
Pharmaceuticals and Biotechnology Co-Development Agreement Trends Analysis Report 2024 with Directory of Deals Singed by 2016 by Company A-Z, Therapy Focus and Technology Type
September 24, 2024 10:40 ET
|
Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Co-Development Deals in Pharmaceuticals and Biotechnology 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.Co-development...
Automated and Closed Cell Therapy Market Research 2024-2029 Featuring Leading Players - Danaher, Thermo Fischer Scientific, Lonza, and Sartorius
September 24, 2024 09:22 ET
|
Research and Markets
Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Automated and Closed Cell Therapy Market 2024-2029" report has been added to ResearchAndMarkets.com's offering. In 2023, the global market...
Pharmaceuticals and Biotechnology Option and Evaluation Deal Trends Report 2024 with Directory of Deals Signed Since 2016
September 23, 2024 06:41 ET
|
Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024" report has been added to ResearchAndMarkets.com's offering. Option and...